New semi-transparent patch delivers effective treatment for tinnitus

Revolutionary, non-surgical EU approved medical device is delivering effective treatment for tinnitus in the form of a semi-transparent patch

Sufferers of tinnitus - an uncontrollable ringing in the ears - are getting some golden silence as Swedish scientists reveal a new treatment for the condition.

The Antinitus medical device patch has received European Regulatory approval with a medical device CE Mark certifying the product's safety and clinical efficacy.

Antinitus, (Antinitus.com), is a self-administered tinnitus treatment that patients can manage themselves and easily integrate into their busy lives.

The treatment involves a 21-day course, and is delivered through a discrete semi-invisible patch which is placed behind the ear every day during the treatment.

Independent clinical studies performed at the Karolinska Trial Alliance / Karolinska Institute and the Sickla ÖNH-centre in Sweden have shown remarkable results for the first-in-class tinnitus product.

In one such clinical trial, reduction in tinnitus severity was achieved by 50% of people at end of the 3-week treatment period, and by 90% at a follow-up assessment 4 weeks after the end of therapy.

In another study 100 patients took part. Patients were required to have suffered from tinnitus for at least 4 weeks before the start of the study.

Treatment with the Antinitus patch for three weeks resulted in a significant decrease in the TSQ* scores from baseline, (P < 0.01). The TSQ score remained decreased at follow-up four weeks after the end of treatment indicating relief from the tinnitus burden. *Tinnitus severity questionnaire.

Added to this are the hugely positive results coming through the Antinitus.com website via a first of its kind post-market-follow-up survey.

Dr. Peter Åhnblad, MD, ENT Senior Consultant Head of Stockholm-Sickla Ear, Nose and Throat Center, Sweden added: "The Antinitus patch is a product that can ultimately give tinnitus patients a more lasting relief of their symptoms."